US Stem Cell Inc (USRM)

[Dragon Lady]

"What a sad state of affairs"- great post Pyrrhonian, very interesting and cogent IMO.

The analysis on how the cash or any "revenues" gets spent on bonuses is very thorough I believe.

Stated:
"For instance, what if the CEO and CSO decided to cap their salaries at $125k and $75k respectively, with no bonuses or stock options going forward (they won't starve right?). That's $575k/yr plus another $200k-$800k relegated to clinical trial research. Well, in 3-4 years, that would equate to $3mm-$6mm in funding. They could easily blow out a decent size randomized Ph II on that. That would produce data to enable partnering, and you're off and running. Instead, they feast."

Great analysis on how much that bonus money could have or would have amounted to if spent on trials- very good take on it IMO. But of course the trials don't appear to be advancing (see latest 10-Q stating "waiting on funding") as all the cash/revenue goes straight to salary boosts and then even bonuses. Great observations IMO.

Volume still way off today and the 50 DMA is solidly broken below the 200 DMA. Long periods where no trades even take place- sometimes an hour or more. We'll have to see I guess.